Showing results (261-270 of 456) with videos related to

Sort By:
Pageof 46
The Kaohsiung Journal of Medical Sciences|October 6, 2020
Eradication of hepatitis C virus preserve liver function and prolong survival in advanced hepatocellular carcinoma patients with limited life expectancyMing-Lun Yeh, Hsing-Tao Kuo, Ching-I Huang, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|July 12, 2017
Boceprevir-based triple therapy to rescue HCV genotype 1/HBV dually infected patients refractory to peginterferon plus ribavirin combination therapy in TaiwanMeng-Hsuan Hsieh, Ming-Lun Yeh, Tung-Hung Su, et al.
The Kaohsiung Journal of Medical Sciences|February 16, 2024
Third vaccine boosters and anti-S-IgG levels: A comparison of homologous and heterologous responses and poor immunogenicity in hepatocellular carcinomaChih-Wen Wang, Chung-Feng Huang, Tyng-Yuan Jang, et al.
Journal of Gastroenterology and Hepatology|August 3, 2019
Ribavirin facilitates early viral kinetics in chronic hepatitis C patients receiving daclatasvir/asunaprevirChung-Feng Huang, Ming-Lun Yeh, Ching-I Huang, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|July 29, 2008
Hepatitis C virus infection among children in aboriginal areas in TaiwanTa-Chung Wu, Wan-Long Chuang, Chia-Yen Dai, et al.
The American Journal of Gastroenterology|July 19, 2008
Reappraisal of the characteristics of glucose abnormalities in patients with chronic hepatitis C infectionJee-Fu Huang, Ming-Lung Yu, Chia-Yen Dai, et al.
Pageof 46